Conflicting accounts from former vaccine advisers left the future of the US government's immunization committee unclear on March 20, 2026, four days after a federal judge stayed 13 appointments and the votes those members had taken.
The legal order did not abolish the Advisory Committee on Immunization Practices, or ACIP. It temporarily removed the challenged appointees from service and paused their decisions while litigation continued. What federal officials planned to do next was a separate question—and public statements did not agree.
The material new event was not another court ruling. It was the absence of a settled, authoritative account of whether HHS would appeal, select replacement members or pursue both paths.
Malone Announced a Decision, Then Retracted It
Robert Malone, a former ACIP co-chair, wrote that the committee had been “disbanded” and would be recreated because that would take less time than an appeal. He later said officials were trying to walk back the plan.
Hours later, Malone changed his account. He said he had been told there was a miscommunication, that no decision had been made and that dissolving and reforming the committee was only one option under consideration.
The correction matters because Malone was not speaking through an HHS announcement. His initial statement described a settled government plan; his later statement acknowledged that the plan was unsettled.
HHS Rejected Unofficial Accounts
An HHS spokesperson told the Guardian that assertions about the department's next move were baseless speculation unless HHS announced them officially. A person familiar with officials' thinking likewise said no final decision had been made.
A former committee member offered a different account, saying officials planned to begin a new selection process. The same report said acting CDC head Jay Bhattacharya had told ACIP chair Kirk Milhoan that new members would be selected because an appeal could take longer.
Those statements documented internal discussion, not a published appointment notice or appeal. As of the Guardian's March 20 report, no appeal had been filed. Readers could therefore identify the options under discussion without treating any one account as final policy.
Four Members Were Outside the Stay
The March 16 order applied to 13 appointments challenged by the plaintiffs. The Guardian reported that four other people appointed more recently remained members because they were not covered by that relief. ACIP itself is required by law to exist.
That distinction undercuts the claim that the court erased the committee as an institution. The immediate problem was whether the remaining membership could support committee work and how HHS would create a legally defensible panel after the challenged appointments and votes were stayed.
The court also paused the January childhood immunization schedule memorandum. Its exact legal reasoning and remedy are addressed in the separate report on the March 16 order. This follow-up concerns the administrative response and the contradictory information released afterward.
Uncertainty Became a Governance Failure
The administration eventually filed an appeal on April 29, and Georgetown Law's litigation tracker lists the district-court case as stayed pending that appeal. That later step resolved one part of the March 20 uncertainty; it did not make the conflicting statements at the time accurate.
An advisory system cannot ask clinicians and the public to trust a decision process that its own participants describe inconsistently. Whether HHS chose appeal, replacement appointments or both, it needed an official account identifying who could serve, which votes remained operative and what legal process would govern the next meeting.
The issue was therefore narrower than the science of any individual vaccine and broader than one mistaken post. ACIP's authority depends on a traceable process. When unofficial declarations outrun agency decisions, the government creates uncertainty that a technically correct later filing cannot retroactively prevent.